These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 33965380)

  • 1. RNA modifications in cardiovascular diseases, the potential therapeutic targets.
    Wu Y; Zhan S; Xu Y; Gao X
    Life Sci; 2021 Aug; 278():119565. PubMed ID: 33965380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential regulatory role of epigenetic RNA methylation in cardiovascular diseases.
    Komal S; Zhang LR; Han SN
    Biomed Pharmacother; 2021 May; 137():111376. PubMed ID: 33588266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Wu S; Zhang S; Wu X; Zhou X
    Mol Ther; 2020 Oct; 28(10):2111-2119. PubMed ID: 32910911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiac methylome: A hidden layer of RNA modifications to regulate gene expression.
    Rajan KS; Ramasamy S; Garikipati VNS; Suvekbala V
    J Mol Cell Cardiol; 2021 Mar; 152():40-51. PubMed ID: 33279505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA modifications in aging-associated cardiovascular diseases.
    Yang X; Gokulnath P; Lehmann HI; Hou Z; Yang S; You L; Zhang G; Xing Y; Lei J; Li G; Guo S; Shang H
    Aging (Albany NY); 2022 Sep; 14(19):8110-8136. PubMed ID: 36178367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA methylation: A potential therapeutic target in autoimmune disease.
    Li L; Xia X; Yang T; Sun Y; Liu X; Xu W; Lu M; Cui D; Wu Y
    Int Rev Immunol; 2024 May; 43(3):160-177. PubMed ID: 37975549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Base-Resolution Sequencing Methods for Whole-Transcriptome Quantification of mRNA Modifications.
    Zhang LS; Dai Q; He C
    Acc Chem Res; 2024 Jan; 57(1):47-58. PubMed ID: 38079380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic role of N6-methyladenosine (m6A) RNA methylation in the cardiovascular system.
    Zhao K; Yang CX; Li P; Sun W; Kong XQ
    J Zhejiang Univ Sci B; 2020 Jul; 21(7):509-523. PubMed ID: 32633106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitranscriptomic Regulations in the Heart.
    Benak D; Kolar F; Hlavackova M
    Physiol Res; 2024 Apr; 73(Suppl 1):S185-S198. PubMed ID: 38634649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
    Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development.
    Haran V; Lenka N
    Stem Cell Rev Rep; 2019 Aug; 15(4):474-496. PubMed ID: 31123982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA modifications and cancer.
    Haruehanroengra P; Zheng YY; Zhou Y; Huang Y; Sheng J
    RNA Biol; 2020 Nov; 17(11):1560-1575. PubMed ID: 31994439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Messenger RNA modifications: Form, distribution, and function.
    Gilbert WV; Bell TA; Schaening C
    Science; 2016 Jun; 352(6292):1408-12. PubMed ID: 27313037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-Adenosine Methylation (m
    Chen YS; Ouyang XP; Yu XH; Novák P; Zhou L; He PP; Yin K
    J Cardiovasc Transl Res; 2021 Oct; 14(5):857-872. PubMed ID: 33630241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA Epigenetics in Chronic Lung Diseases.
    Wang X; Guo Z; Yan F
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interplay within the epitranscriptome: Reality or fiction?
    Worpenberg L; Paolantoni C; Roignant JY
    Bioessays; 2022 Feb; 44(2):e2100174. PubMed ID: 34873719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of mRNA methylation in normal and pathological behavior.
    Engel M; Chen A
    Genes Brain Behav; 2018 Mar; 17(3):e12428. PubMed ID: 29027751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of m
    Nombela P; Miguel-López B; Blanco S
    Mol Cancer; 2021 Jan; 20(1):18. PubMed ID: 33461542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA modification in cardiovascular disease: implications for therapeutic interventions.
    Wang C; Hou X; Guan Q; Zhou H; Zhou L; Liu L; Liu J; Li F; Li W; Liu H
    Signal Transduct Target Ther; 2023 Oct; 8(1):412. PubMed ID: 37884527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA epigenetics and cardiovascular diseases.
    Dorn LE; Tual-Chalot S; Stellos K; Accornero F
    J Mol Cell Cardiol; 2019 Apr; 129():272-280. PubMed ID: 30880252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.